InMode Holds Quarterly Revenue at $95.6 Million and Reaffirms 2026 Outlook

Silexion Reports Three-Pathway Immune Sensitization in SIL204 Cancer Study

BridgerPay Says AI Rerouting Recovered $55 Million for Israeli Businesses

Selected story

NeuroThera Launches Yale Phase IIb Trial for Tourette Syndrome Treatment

Odysight Signs Boeing Agreement to Demonstrate Predictive-Maintenance AI

Bezeq Raises 2026 Profit Forecast to as Much as NIS 1.2 Billion

NeuroThera Launches Yale Phase IIb Trial for Tourette Syndrome Treatment

Something went wrong

We couldn't complete that action. Check your connection and try again.